Cite Filings / SPRY / 0001949846-24-000390
Feed Companies Filings Check
Sign in
144

Sale of Securities

ARS Pharmaceuticals, Inc. · Filed 2024-07-16 · Acc 0001949846-24-000390

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2024-08-13 144 Sale of Securities
  • 2024-07-18 4 PRESIDENT AND CEO sold 100,000 shares at an average $11.40 ($1,140,295)
  • 2024-07-18 4 CHIEF MEDICAL OFFICER sold 100,000 shares at an average $11.40 ($1,140,295)
  • 2024-07-16 144 Sale of Securities
  • 2024-07-11 4 CHIEF MEDICAL OFFICER sold 100,000 shares at an average $9.62 ($961,725)
  • 2024-07-11 4 PRESIDENT AND CEO sold 100,000 shares at an average $9.62 ($961,725)
  • 2024-06-11 144 Sale of Securities

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…